
New Wearable Device Uses Electric Fields to Treat Glioblastomas
Optune device can prolong GBM life expectancy for an average of three months
Optune device can prolong GBM life expectancy for an average of three months
At the American Society of Clinical Oncology Annual Meeting 2017 in Chicago, researchers presented promising data for two different investigational drug regimens used to treat melanoma that has spread to the brain, a common and deadly complication of this cancer.
Brain Cancer, Brain Health, Cancer, Melanoma, News, Treatment
UNC Lineberger researchers led by Dr. Timothy R. Gershon report preclinical findings showing promise for targeting a gene linked to microcephaly in infants as a treatment for medulloblastoma.